Condensed Consolidated Statements of Profit or (Loss) and Other Comprehensive Income or (Loss) - EUR (€) € in Thousands |
3 Months Ended | 9 Months Ended | ||||
|---|---|---|---|---|---|---|
Sep. 30, 2024 |
Sep. 30, 2023 |
Sep. 30, 2024 |
Sep. 30, 2023 |
|||
| Profit or loss [abstract] | ||||||
| Revenue | € 57,833 | € 48,034 | € 189,725 | € 129,016 | ||
| Cost of sales | 11,201 | 7,388 | 30,235 | 24,938 | ||
| Gross profit | 46,632 | 40,646 | 159,490 | 104,078 | ||
| Research and development costs | 73,544 | 111,439 | 227,708 | 322,573 | ||
| Selling, general and administrative expenses | 69,831 | 63,614 | 210,928 | 200,435 | ||
| Operating profit/(loss) | (96,743) | (134,407) | (279,146) | (418,930) | ||
| Share of profit/(loss) of associates | (4,367) | (6,794) | (15,485) | (15,471) | ||
| Finance income | 28,279 | 4,142 | 29,262 | 76,985 | ||
| Finance expenses | 25,347 | 24,519 | 70,488 | 35,640 | ||
| Profit/(loss) before tax | (98,178) | (161,578) | (335,857) | (393,056) | ||
| Income taxes/(expenses) | (1,020) | (645) | (3,758) | (1,513) | ||
| Net profit/(loss) for the period | (99,198) | (162,223) | (339,615) | (394,569) | ||
| Attributable to owners of the Company | € (99,198) | € (162,223) | € (339,615) | € (394,569) | ||
| Basic earnings/(loss) per share | € (1.72) | € (2.88) | € (5.93) | € (7.02) | ||
| Diluted earnings/(loss) per share | € (1.72) | € (2.88) | € (5.93) | € (7.02) | ||
| Number of shares used for calculation (basic and diluted) | [1] | 57,535,349 | 56,272,698 | 57,255,764 | 56,194,956 | |
| Statement of comprehensive income [abstract] | ||||||
| Net profit/(loss) for the period | € (99,198) | € (162,223) | € (339,615) | € (394,569) | ||
| Items that may be reclassified subsequently to profit or (loss): | ||||||
| Exchange differences on translating foreign operations | 154 | 571 | 232 | (1,232) | ||
| Other comprehensive income/(loss) for the period, net of tax | 154 | 571 | 232 | (1,232) | ||
| Total comprehensive income/(loss) | (99,044) | (161,652) | (339,383) | (395,801) | ||
| Attributable to owners of the Company | € (99,044) | € (161,652) | € (339,383) | € (395,801) | ||
| ||||||
| X | ||||||||||
- Definition The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of comprehensive income attributable to owners of the parent. [Refer: Comprehensive income] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of costs associated with financing activities of the entity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of income associated with interest and other financing activities of the entity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue] Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of other comprehensive income, net of tax, after reclassification adjustments, related to exchange differences when financial statements of foreign operations are translated. [Refer: Other comprehensive income] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of other comprehensive income that will be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income] Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The profit (loss) before tax expense or income. [Refer: Profit (loss)] Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The profit (loss) from operating activities of the entity. [Refer: Profit (loss)] Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of expenditure directly attributable to research or development activities, recognised in profit or loss. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of expense relating to selling, general and administrative activities of the entity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The entity's share of the profit (loss) of associates accounted for using the equity method. [Refer: Total for all associates [member]; Investments accounted for using equity method; Profit (loss)] Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|